Similar articles

• Five-year serial renal graft biopsy study in cyclosporine-treated patients.

  Wilczek H, Bohman SO, Klintmalm G, Groth CG. Wilczek H, et al. Transplant Proc. 1988 Jun;20(3 Suppl 3):812-5. Transplant Proc. 1988. PMID: 3291319 No abstract available.
• Triple therapy with low-dose cyclosporine, azathioprine, and steroids: long-term results of a randomized study in cadaver donor renal transplantation.

  Fries D, Hiesse C, Santelli G, Gardin JP, Cantarovich M, Lantz O, Charpentier B, Paillard M, Benoit G. Fries D, et al. Transplant Proc. 1988 Jun;20(3 Suppl 3):130-5. Transplant Proc. 1988. PMID: 3291226 Clinical Trial. No abstract available.
• An update on the use of low-dose maintenance cyclosporine A therapy after renal transplantation.

  Karmi SA, DePalma R, Bosch J, Dosa S, Michell A. Karmi SA, et al. Transplant Proc. 1988 Jun;20(3 Suppl 3):110-3. Transplant Proc. 1988. PMID: 3291218 No abstract available.
• Histopathology of cyclosporine nephrotoxicity.

  Mihatsch MJ, Thiel G, Ryffel B. Mihatsch MJ, et al. Transplant Proc. 1988 Jun;20(3 Suppl 3):759-71. Transplant Proc. 1988. PMID: 3291311 Review. No abstract available.
• Comparative pathophysiology and histopathology of cyclosporine nephrotoxicity.

  Dieperink H, Starklint H, Kemp E, Leyssac PP. Dieperink H, et al. Transplant Proc. 1988 Jun;20(3 Suppl 3):785-91. Transplant Proc. 1988. PMID: 3291315 Review. No abstract available.